Marktanalyse - Analgesics in Germany

As in previous years, within overall retail value sales of analgesics, a trend away from systemic towards topical was seen in Germany in 2011. There were many factors behind the overall decline in systemic analgesics, for example recent restrictions on self-medication pack sizes as well as consumers’ reluctance to treat minor pains with systemic analgesics, while topical analgesics were able to benefit from their growing target group of older users.

Euromonitor International's Analgesics in Germany report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2007-2011, allowing you to identify the sectors driving growth. Forecasts to 2016 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Analgesics market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

ANALGESICS IN GERMANY

Euromonitor International

July 2012



LIST OF CONTENTS AND TABLES



Headlines

Trends

Switches

Competitive Landscape

Prospects

Category Data

Table 1 Sales of Analgesics by Category: Value 2006-2011

Table 2 Sales of Analgesics by Category: % Value Growth 2006-2011

Table 3 Topical Analgesics/Anaesthetic by Format: % Value Breakdown 2006-2011

Table 4 Analgesics Company Shares by Value 2007-2011

Table 5 Analgesics Brand Shares by Value 2008-2011

Table 6 Forecast Sales of Analgesics by Category: Value 2011-2016

Table 7 Forecast Sales of Analgesics by Category: % Value Growth 2011-2016

Bayer Vital GmbH in Consumer Health (germany)

Strategic Direction

Key Facts

Summary 1 Bayer Vital GmbH: Key Facts

Summary 2 Bayer Vital GmbH: Operational Indicators

Company Background

Production

Summary 3 Bayer Vital GmbH: Production Statistics 2011

Competitive Positioning

Summary 4 Bayer Vital GmbH: Competitive Position 2011

Hexal AG in Consumer Health (germany)

Strategic Direction

Key Facts

Summary 5 Hexal AG: Key Facts

Summary 6 Hexal AG: Operational Indicators

Company Background

Production

Summary 7 Hexal AG: Production Statistics 2011

Competitive Positioning

Summary 8 Hexal AG: Competitive Position 2011

Johnson & Johnson GmbH in Consumer Health (germany)

Strategic Direction

Key Facts

Summary 9 Johnson & Johnson GmbH: Key Facts

Summary 10 Johnson & Johnson GmbH: Operational Indicators

Company Background

Production

Competitive Positioning

Summary 11 Johnson & Johnson GmbH: Competitive Position 2011

Mann Chem-pharm Fabrik Gmbh, Dr Gerhard in Consumer Health (germany)

Strategic Direction

Key Facts

Summary 12 Mann Chem-Pharm Fabrik GmbH, Dr Gerhard: Key Facts

Summary 13 Mann Chem-Pharm Fabrik GmbH, Dr Gerhard: Operational Indicators

Company Background

Production

Competitive Positioning

Summary 14 Mann Chem-Pharm Fabrik GmbH, Dr Gerhard: Competitive Position 2011

Novartis Consumer Health GmbH in Consumer Health (germany)

Strategic Direction

Key Facts

Summary 15 Novartis Consumer Health GmbH: Key Facts

Summary 16 Novartis Deutschland GmbH: Operational Indicators

Company Background

Production

Summary 17 Novartis Deutschland GmbH: Production Statistics 2011

Competitive Positioning

Summary 18 Novartis Consumer Health GmbH: Competitive Position 2011

Ratiopharm GmbH & Co in Consumer Health (germany)

Strategic Direction

Key Facts

Summary 19 Ratiopharm GmbH & Co: Key Facts

Summary 20 Ratiopharm GmbH & Co: Operational Indicators

Company Background

Production

Summary 21 Ratiopharm GmbH & Co: Production Statistics 2011

Competitive Positioning

Summary 22 Ratiopharm GmbH & Co: Competitive Position 2011

Stada Arzneimittel AG in Consumer Health (germany)

Strategic Direction

Key Facts

Summary 23 STADA Arzneimittel AG: Key Facts

Summary 24 STADA Arzneimittel AG: Operational Indicators

Company Background

Production

Competitive Positioning

Summary 25 STADA Arzneimittel AG: Competitive Position 2011

Executive Summary

Consumer Health Overall Stagnating in Germany in 2011

Market Under Pressure From Healthier Diets and More Exercise

Very Fragmented Market Continues To Be Led by Bayer Vital

Consumer Healthcare Most Often Sold in Health and Beauty Retailers

Small Decline of Consumer Health Expected Over Forecast Period in Germany

Key Trends and Developments

Ongoing Relatively Favourable Economic Conditions in Germany in 2011

Demographic Changes Continue To Influence Consumer Health in Germany

Increasing Shares of Sales Through Internet Retailing in Consumer Health

Consumer Lifestyle Issues Offer Opportunities for Manufacturers and Retailers

Innovation Essential for Premium Brands To Thrive in Consumer Health

Market Indicators

Table 8 Consumer Expenditure on Health Goods and Medical Services 2006-2011

Table 9 Life Expectancy at Birth 2006-2011

Market Data

Table 10 Sales of Consumer Health by Category: Value 2006-2011

Table 11 Sales of Consumer Health by Category: % Value Growth 2006-2011

Table 12 Consumer Health Company Shares 2007-2011

Table 13 Consumer Health Brand Shares 2008-2011

Table 14 Penetration of Private Label by Category 2006-2011

Table 15 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011

Table 16 Sales of Consumer Health by Category and Distribution Format: % Analysis 2011

Table 17 Forecast Sales of Consumer Health by Category: Value 2011-2016

Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016

Appendix

OTC Registration and Classification

Vitamins and Dietary Supplements Registration and Classification

Switches

Summary 26 OTC - Switches 2010-2011

Definitions

Sources

Summary 27 Research Sources

• Analgesics in Canada
• Analgesics in Denmark
• Analgesics in Hong Kong, China
• Analgesics in Norway
• Analgesics in Turkey
• Cough, Cold and Allergy (Hay Fever) Remedies in Canada
• Cough, Cold and Allergy (Hay Fever) Remedies in Denmark
• Cough, Cold and Allergy (Hay Fever) Remedies in Hong Kong, China
• Cough, Cold and Allergy (Hay Fever) Remedies in Norway
• Cough, Cold and Allergy (Hay Fever) Remedies in Turkey
• Alcohol Addiction – Pipeline Review, H1 2013
• Analgesics in Algeria
• Analgesics in Azerbaijan
• Analgesics in Chile
• Analgesics in China
• Analgesics in Finland
• Analgesics in Greece
• Analgesics in Kazakhstan
• Analgesics in Latvia
• Analgesics in Lithuania